VectorBuilder Obtains European Patent for "MiniVec™" Plasmid System
NQ Score
49/100
N1 Content Completeness
5
AI Summary (NQ-processed)
VectorBuilder announced it has obtained a European patent for its innovative plasmid backbone "MiniVec™," which enhances safety and manufacturing efficiency in the gene medicine field. MiniVec™ reduces reliance on antibiotics and chemical additives through its miniaturized vector backbone design, achieving both efficient large-scale manufacturing and high performance in therapeutic applications. It addresses diverse needs in advanced gene medicines like gene therapy, cell therapy, and vaccine development, contributing to reduced manufacturing costs and strengthened safety and regulatory compliance.